share_log

Analysts Issue Forecasts for Appili Therapeutics Inc.'s FY2023 Earnings (TSE:APL)

Financial News Live ·  Jul 19, 2022 14:01

Appili Therapeutics Inc. (TSE:APL – Get Rating) – Stock analysts at Zacks Small Cap issued their FY2023 earnings per share (EPS) estimates for shares of Appili Therapeutics in a report released on Thursday, July 14th. Zacks Small Cap analyst D. Bautz anticipates that the company will post earnings of ($0.10) per share for the year. Zacks Small Cap also issued estimates for Appili Therapeutics' FY2024 earnings at ($0.07) EPS and FY2025 earnings at ($0.06) EPS.

Appili Therapeutics Price Performance

Read More

  • Is it Time to Cash Out Novavax Stock?
  • Should you buy Bank of America Stock After Its Q2 Earnings Report?
  • Monthly Dividend Stocks Can Provide Solid Income
  • AMC Entertainment Is On Track For Blockbuster Results
  • Why Did State Street's Stock Rally Despite Weaker Earnings?

Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment